Ann-Lii Cheng, MD

home / authors / ann-lii-cheng-md

Articles

Moving Forward From Monotherapy in HCC

Moving Forward From Monotherapy in HCC

October 22nd 2018

Ann-Lii Cheng, MD, discusses where the of hepatocellular carcinoma is headed.

Phase III Findings for Lenvatinib in HCC

Phase III Findings for Lenvatinib in HCC

July 11th 2017

Ann-Lii Cheng, MD, discusses a phase III trial of lenvatinib vs sorafenib in the first-line treatment of patients with unresectable hepatocellular carcinoma.